Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Paradigm Biopharmaceuticals Ltd. has announced a change in the director’s securities holdings, with Paul Rennie disposing of 197,355 fully paid ordinary shares. Despite this reduction, Rennie continues to hold a significant number of shares across various accounts. This move could attract attention from investors watching director trading activities in the company.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
